SHANNON DELUCA: Open Payments
NPI 1780071373 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 59 payments from 15 companies in 2025. Trend: 2023 $2,038 · 2024 $1,853 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $443 |
| Novartis Pharmaceuticals Corporation | 15 | $331 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $269 |
| Medtronic, Inc. | 1 | $236 |
| Abbott Laboratories | 4 | $194 |
| SCPHARMACEUTICALS INC. | 3 | $160 |
| Novo Nordisk Inc | 3 | $123 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Kestra Medical Technology Services, Inc. | 3 | $59 |
Products named: WAINUA, LEQVIO, Kerendia, COREVALVE EVOLUT R, FUROSCIX, TRICLIP, Ozempic, JARDIANCE.
Industry payments across NC — which companies pay providers there.
